Account Based Marketing (ABM) segment for B2B targeting people who work at Vertex Pharmaceuticals in the Biotechnology industry.  Feel free to add as many companies you like to the shopping cart and we will assist you in activating your campaign in the marketing platforms you choose. Vertex Pharmaceuticals has over   3561. AccountsGraph by Skydeo has 11,628 users available for digital targeting and 3,768 contacts with emails, titles, phone, address, LinkedIn URLs, etc. to update your CRM for account-based marketing.

You may reference segment ID – 500701077 or by name *AccountsGraph.com > Biotechnology > Vertex Pharmaceuticals.

About Vertex Pharmaceuticals: Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For six years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.comVertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.. vrtx.com

SIC CODE: 8721

AccountsGraph taxonomy is available for Google, Facebook, TikTok, Snapchat, The Trade Desk, Verizon Media Yahoo, and many more via LiveRamp.  Please contact us if  you have any questions.